Literature DB >> 25437696

[Sugammadex versus neostigmine in pediatric patients: a prospective randomized study].

Turhan Kara1, Ozgur Ozbagriacik1, Hacer Sebnem Turk1, Canan Tulay Isil2, Ozan Gokuc1, Oya Unsal1, Emrah Seyhan1, Sibel Oba1.   

Abstract

BACKGROUND AND OBJECTIVES: Acetylcholinesterase inhibitors may cause postoperative residual curarization when they are used for reversal of neuromuscular blockade. Sugammadex reverses neuromuscular blockade by chemical encapsulation and is not associated with the side effects that may occur with the use of anticholinesterase agents. Because of increased outpatient surgical procedures postoperative residual curarization and rapid postoperative recovery have a greater importance in the pediatric patient population. The aim of this study was to compare the efficacy of sugammadex and neostigmine on reversing neuromuscular blockade in pediatric patients undergoing outpatient surgical procedures.
METHODS: 80 patients, aged 2-12 years, scheduled for outpatient surgery were enrolled in this randomized prospective study. Neuromuscular blockade was achieved with 0.6mgkg(-1) rocuronium and monitorized with train-of-four. Group RN (n=40) received 0.03mgkg(-1) neostigmine, Group RS (n=40) received 2mgkg(-1) sugammadex for reversal of rocuronium. Extubation time (time from the reversal of neuromuscular blockade to extubation), train-of-four ratio during this time, time to reach train-of-four>0.9, and probable complications were recorded.
RESULTS: There was no significant difference between the patients' characteristics. Extubation time and time to reach train-of-four>0.9 were significantly higher in Group RN (p=0.001, p=0.002). Train-of-four at the time of neostigmine/sugammadex injection in Group RN were significantly higher than in the RS group (p=0.020). Extubation train-of-four ratio was significantly lower in Group RN (p=0.002).
CONCLUSION: Sugammadex provides safer extubation with a shorter recovery time than neostigmine in pediatric patients undergoing outpatient surgical procedures.
Copyright © 2014 Sociedade Brasileira de Anestesiologia. Publicado por Elsevier Editora Ltda. All rights reserved.

Entities:  

Keywords:  Neostigmina; Neostigmine; Pediatria; Pediatric; Sugammadex

Year:  2014        PMID: 25437696     DOI: 10.1016/j.bjan.2014.03.001

Source DB:  PubMed          Journal:  Rev Bras Anestesiol        ISSN: 0034-7094            Impact factor:   0.964


  7 in total

Review 1.  Efficacy and safety of sugammadex versus neostigmine in reversing neuromuscular blockade in adults.

Authors:  Ana-Marija Hristovska; Patricia Duch; Mikkel Allingstrup; Arash Afshari
Journal:  Cochrane Database Syst Rev       Date:  2017-08-14

2.  Sugammadex in awakening from general anesthesia: systematic review and meta-analysis.

Authors:  Adriano Anzai; Armelin Utino; Giuliano Tosello; Haroldo Katayama; Ighor Alexander Zamuner Spir; Luca Schiliró Tristão; Mary Martins Nery; Mauricio Anhesini; Osvaldo Silvestrini Tiezzi; Patricia Rodrigues Naufal Spir; Pericles Otani; Wanderley Marques Bernado
Journal:  Rev Assoc Med Bras (1992)       Date:  2022-09       Impact factor: 1.712

3.  Efficacy and safety of sugammadex for neuromuscular blockade reversal in pediatric patients: an updated meta-analysis of randomized controlled trials with trial sequential analysis.

Authors:  Bingchen Lang; Lu Han; Linan Zeng; Qianqian Zhang; Shouming Chen; Liang Huang; Zhijun Jia; Qin Yu; Lingli Zhang
Journal:  BMC Pediatr       Date:  2022-05-19       Impact factor: 2.567

4.  Sugammadex for reversal of rocuronium-induced neuromuscular blockade in pediatric patients: A systematic review and meta-analysis.

Authors:  Young Ju Won; Byung Gun Lim; Dong Kyu Lee; Heezoo Kim; Myoung Hoon Kong; Il Ok Lee
Journal:  Medicine (Baltimore)       Date:  2016-08       Impact factor: 1.889

5.  Myasthenia gravis and sugammadex: A case report and review of the literature.

Authors:  Sujana Dontukurthy; Carrie Wisler; Vidya Raman; Joseph D Tobias
Journal:  Saudi J Anaesth       Date:  2020-03-05

6.  The efficacy and safety of sugammadex for reversing postoperative residual neuromuscular blockade in pediatric patients: A systematic review.

Authors:  Guangyu Liu; Rui Wang; Yanhong Yan; Long Fan; Jixiu Xue; Tianlong Wang
Journal:  Sci Rep       Date:  2017-07-18       Impact factor: 4.379

7.  Recovery Profile of Sugammadex versus Neostigmine in Pediatric Patients Undergoing Cardiac Catheterization: A Randomized Double-Blind Study.

Authors:  Hosam I El Said Saber; Sherif A Mousa; Ahmed Refaat AbouRezk; A Zaglool
Journal:  Anesth Essays Res       Date:  2022-02-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.